[Probiotics and prebiotics for the prevention and treatment of atopic eczema]

Area of Science:

• Immunology
• Microbiology
• Dermatology

Context:

• Rising incidence of atopic diseases in industrialized nations necessitates effective primary prevention strategies.
• Atopic eczema prevalence is increasing globally, particularly in Western countries.
• Current prevention methods require further development for cost-effectiveness and broad applicability.

Purpose:

• To evaluate the efficacy of probiotic lactic acid bacteria in preventing atopic eczema.
• To explore the role of prebiotics, such as fructooligosaccharides and galactooligosaccharides, in modulating gut microbiota for allergic disease prevention.
• To investigate the correlation between bifidobacteria levels and atopic eczema severity.

Summary:

• Probiotic lactic acid bacteria demonstrate potential for atopic eczema prevention, with promising therapeutic outcomes observed in infants presenting with mild to moderate skin lesions and elevated immunoglobulin E levels.
• Prebiotics like fructooligosaccharides and galactooligosaccharides can increase bifidobacteria counts in the colon, though their specific benefits in managing allergic diseases require further elucidation.
• A correlation has been identified between the abundance of bifidobacteria and the severity of atopic eczema in affected patients.

Impact:

• Findings suggest a targeted approach for probiotic interventions in atopic eczema, focusing on specific infant populations.
• Highlights the need for further research into the mechanisms by which gut microbiota modulation influences allergic disease development and progression.
• Provides a basis for developing novel, microbiota-targeted strategies for the primary prevention and management of atopic diseases.